Business process automation

Automation will cost jobs — and create more: study

ONE IN five medium-sized businesses in the UK believes that automation will help them compete with larger rivals. Larger firms have so far been quicker...
Bitcoin accepted here

Good reasons cryptocurrency is likely to become ‘the future of commerce’

Analyst BRIAN G. SEWELL speculates that Bitcoin et al, although flawed, will change the way the world does business I WOULD rather see the SEC...
Moving car at night

Want to speed-up your start-up? An accelerator may be the answer

Successful participants in this scheme could evolve into $100m-evaluated companies, under the guidance of experts. THE Holt Accelerator team is on the search for the...
Currencies paying for ICO

IC… oh, dear! Initial coin offerings can, and do, go wrong, so ‘caveat investor’

Do some Google research on ICOs and you will immediately hear the faint, but unmistakable, clang of warning bells. Bells that almost – but...
Ethereum

The crypto balloon is rising again, with new player Ethereum hanging on tight

By HAL WILLIAMS BITCOIN’S value will more than double by the end of 2018. Buy, buy, buy! But, um, not Bitcoin. And hey, relax your shoulders:...
Tesla Model 3

Electric car production has shocks in store for ‘super-entrepreneur’ Musk

ACCORDING to Bloomberg, Tesla – which, whoa, has been in business for 15 years – is burning $6,500 each and every minute. Someone do...
Asteroid mining

There’s platinum in them there stars

Goldman Sachs Group predicts a new top-earner will soon be in our midst By HAL WILLIAMS THE American multinational investment bank and financial services company Goldman...
Error in binary code

The fine art of stuffing-up at the right moment to make sense of analytics

Professors of marketing at the Kellogg School, Eric Anderson and Florian Zettelmeyer, recount a story called the Analytics Paradox “A YOUNG firm starts out making...
Gene therapy

Merger brings gene therapy aid for infants closer to production

FDA approves ‘breakthrough therapy’ designation for novel treatment NOVARTIS has announced a multi-billion dollar agreement and plan of merger with AveXis to acquire the US-based...
DNA gene

Sweet gene victory around the corner? Therapeutic advances come rolling in

As the UK Government opens its new ‘Catapult’ centre devoted to gene therapy manufacturing, could 2018 be the year of its mainstream commercialisation? BV’s...